SARC006

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

TYPE OF SARCOMA: Malignant peripheral nerve sheath tumors sporadic or NF1 associated
DRUG: Adriamycin/ifosfamide and Adriamycin/etoposide

ACCRUAL STATUS: Completed

OVERALL STUDY PRINCIPAL INVESTIGATOR:
Brigitte C. Widemann, MD
National Cancer Institute (NCI)

CLINICALTRIALS.GOV IDENTIFIER: NCT00304083

FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV

PUBLICATION:
Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke D, Long L, Viskochil D, Baker L, Widemann BC. SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors. Sarcoma. 2017;2017:8685638. doi: 10.1155/2017/8685638. Epub 2017 Sep 12. PMID: 29138631; PMCID: PMC5613633.

To learn more about this study or to contact the study research staff: